THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 91 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $793,000 | -15.7% | 23,161 | -1.9% | 0.00% | -25.0% |
Q2 2017 | $941,000 | +8.0% | 23,621 | -0.1% | 0.00% | 0.0% |
Q1 2017 | $871,000 | +11.7% | 23,648 | -3.3% | 0.00% | +33.3% |
Q4 2016 | $780,000 | -9.2% | 24,465 | +3.2% | 0.00% | -25.0% |
Q3 2016 | $859,000 | +32.4% | 23,695 | -17.1% | 0.00% | +33.3% |
Q2 2016 | $649,000 | +86.5% | 28,591 | +54.3% | 0.00% | +50.0% |
Q1 2016 | $348,000 | +17.2% | 18,532 | +2.3% | 0.00% | +100.0% |
Q4 2015 | $297,000 | +65.0% | 18,110 | +10.6% | 0.00% | 0.0% |
Q3 2015 | $180,000 | -15.5% | 16,369 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $213,000 | -28.8% | 16,369 | -5.0% | 0.00% | 0.0% |
Q1 2015 | $299,000 | +12.8% | 17,229 | -3.2% | 0.00% | 0.0% |
Q4 2014 | $265,000 | -36.5% | 17,792 | -1.6% | 0.00% | -50.0% |
Q3 2014 | $417,000 | -27.9% | 18,080 | -0.2% | 0.00% | 0.0% |
Q2 2014 | $578,000 | – | 18,116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
Baupost Group | 7,419,226 | $64,028 | 1.23% |
Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |